Form 4: Cognex Director Willett Reports RSU Vesting, Tax Sale
Insider Transaction Report
Cognex Director Robert Willett reported the vesting of 14,165 restricted stock units and the subsequent sale of 6,849 shares to cover tax obligations.
Summary
- Robert Willett, a Director at Cognex Corp (CGNX), reported transactions related to his beneficial ownership.
- On February 18, 2026, 14,165 restricted stock units (RSUs) vested, resulting in the acquisition of 14,165 shares of Common Stock at a price of $0.0 per share.
- Concurrently, 6,849 shares of Common Stock were disposed of at a price of $56.72 per share to satisfy tax withholding obligations related to the RSU vesting.
- Following these transactions, Mr. Willett indirectly beneficially owns 23,120 shares of Common Stock through the Willett Parkhill Investment Trust.
- Mr. Willett also holds various non-qualified stock options to buy Common Stock, with exercise prices ranging from $33.04 to $90.50 and expiration dates between February 19, 2029, and February 18, 2035.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing a routine insider transaction involving the vesting of restricted stock units and a subsequent sale to cover tax obligations, which is common practice.
Positives
- The vesting of 14,165 restricted stock units represents a realization of compensation for Director Robert Willett.
Negatives
- A disposition of 6,849 shares of Common Stock occurred to cover tax withholding obligations, reducing the director's indirect beneficial ownership.
Future Outlook
This filing is a report of insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider trading activity and typically do not provide insights into broader industry trends or competitive dynamics. These transactions reflect individual compensation and tax planning rather than strategic shifts.
Related Party Transactions
- The reporting person, Robert Willett, is a trustee and beneficiary of the Willett Parkhill Investment Trust dated August 2, 2010, through which 23,120 shares are indirectly beneficially owned. Mr. Willett disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine insider compensation event and tax-related sale, not indicative of a change in company fundamentals or strategy.
- Employees: No direct impact mentioned.
Next Steps
- Future vesting of remaining Restricted Stock Units on the second and third anniversaries of the February 18, 2025 grant date.
Key Dates
| Date | Description |
|---|---|
| 2010-08-02 | Date of Willett Parkhill Investment Trust. |
| 2019-02-20 | Grant date for Non-Qualified Stock Option (right to buy) with an exercise price of $56.44, expiring on February 20, 2028. |
| 2020-02-19 | Grant date for Non-Qualified Stock Option (right to buy) with an exercise price of $51.49, expiring on February 19, 2029. |
| 2021-02-18 | Grant date for Non-Qualified Stock Option (right to buy) with an exercise price of $50.94, expiring on February 18, 2030. |
| 2022-02-16 | Grant date for Non-Qualified Stock Option (right to buy) with an exercise price of $90.50, expiring on February 16, 2031. |
| 2023-02-22 | Grant date for Non-Qualified Stock Option (right to buy) with an exercise price of $64.43, expiring on February 22, 2032. |
| 2024-02-21 | Grant date for Non-Qualified Stock Option (right to buy) with an exercise price of $47.21, expiring on February 21, 2033. |
| 2025-02-18 | Grant date for Restricted Stock Units, with vesting scheduled approximately 20%, 30%, and 50% on the first, second, and third anniversaries, respectively. |
| 2025-02-20 | Grant date for Non-Qualified Stock Option (right to buy) with an exercise price of $39.44, expiring on February 20, 2034. |
| 2026-02-18 | Transaction date for the vesting of 14,165 Restricted Stock Units and the disposition of 6,849 shares for tax withholding. Also, the date the Restricted Stock Units became exercisable. |
| 2026-02-19 | Date the Form 4 was signed by Robert Willett. |
| 2026-02-18 | Grant date for Non-Qualified Stock Option (right to buy) with an exercise price of $33.04, expiring on February 18, 2035. |
| 2028-02-18 | Expiration date for the Restricted Stock Units. |
Keywords
Cognex, CGNX, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Stock Options, Beneficial Ownership, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.